Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Jodi L. Liu"'
In 2010, 15 percent of Americans older than age 70 had dementia. By 2050, the number of new dementia cases among those 65 and older is expected to double. This blueprint outlines policy options to help decisionmakers improve dementia long-term servic
Publikováno v:
Health Affairs. 41:516-522
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2af5d2ea9fd39dc79e45413299633d0
https://doi.org/10.1377/hlthaff.2021.01476
https://doi.org/10.1377/hlthaff.2021.01476
Autor:
Lane F, Burgette, Joachim O, Hero, Jodi L, Liu, Catherine C, Cohen, Barbara O, Wynn, Katie, Merrell, Drew M, Anderson, Daniel J, Crespin, Stephanie, Dellva, Roald, Euller
Publikováno v:
Rand Health Q
Each year, Medicare allocates tens of billions of dollars for indirect practice expense (PE) across services on the basis of data from the Physician Practice Information (PPI) Survey, which reflects 2006 expenses. Because these data are not regularly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3ebacbbb6e9d5735650dad58e48e307
https://pubmed.ncbi.nlm.nih.gov/36238018
https://pubmed.ncbi.nlm.nih.gov/36238018
Accounting for the burden and redistribution of health care costs: Who uses care and who pays for it
Publikováno v:
Health Services Research
Objective To measure the burden of financing health care costs and quantify redistribution among population groups. Data Sources A synthetic population using data combined from multiple sources, including the Survey of Income and Program Participatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e7a10ef2ba8e512c7c15002816067d
https://pubmed.ncbi.nlm.nih.gov/31984503
https://pubmed.ncbi.nlm.nih.gov/31984503
This brief describes how a public option for health care—that is, a government-sponsored health insurance plan with publicly determined provider payment rates—would affect insurance costs and coverage.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::073c36c13d99063433765a410890f031
https://doi.org/10.7249/rb10120
https://doi.org/10.7249/rb10120
Autor:
Barbara O. Wynn, Nabeel Qureshi, Roald Euller, Stephanie Dellva, Joachim O. Hero, Lan Zhao, Liisa Hiatt, Evan D. Peet, Catherine C. Cohen, Lane F. Burgette, Daniel J. Crespin, Yaou Flora Sheng, Monique Martineau, Vishnupriya Kareddy, Katie Merrell, PhuongGiang Nguyen, Teague Ruder, Jodi L. Liu, Peter S. Hussey
Key data used to set practice expense (PE) payment rates under the Medicare Physician Fee Schedule have not been updated since 2008, though the U.S. economy and health care system have changed since then. There are concerns that continued reliance on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e531cbe0e528695d4abfd59a9fa36ae8
https://doi.org/10.7249/rr3248
https://doi.org/10.7249/rr3248
Autor:
Robert H. Brook, Jodi L. Liu
Publikováno v:
Journal of General Internal Medicine. 32:822-831
Single-payer systems have been proposed as a health care reform alternative in the United States. However, there is no consensus on the definition of single-payer. Most definitions characterize single-payer as one entity that collects funds and pays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fec53ffb7dc1f073261c295640cf59e
https://doi.org/10.1007/s11606-017-4063-5
https://doi.org/10.1007/s11606-017-4063-5
Publikováno v:
Health Affairs. 36:697-705
In 2015, Congress repealed the Sustainable Growth Rate formula for Medicare physician payment, eliminating mandatory payment cuts when spending exceeded what was budgeted. In its place, Congress enacted the Medicare Access and CHIP Reauthorization Ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c156955c5efd6199600868c249563847
https://doi.org/10.1377/hlthaff.2016.0559
https://doi.org/10.1377/hlthaff.2016.0559
Publikováno v:
Rand health quarterly. 8(3)
No disease-modifying therapy is currently available for Alzheimer's disease, but therapies are in development, and one may become available in the near future. Based on results from early-stage clinical trials, therapeutic development has focused on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f15e2d90c7ed904ceb72149aebe9fe96
https://pubmed.ncbi.nlm.nih.gov/31205802
https://pubmed.ncbi.nlm.nih.gov/31205802